YJP-14

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameYJP-14
Drug Alias NameYJP-14
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsDiabetes Complications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesHan Wha PharmaYang Ji Chemical
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHan Wha Pharma Co Ltd
Active IndicationsN/A
Inactive IndicationsDiabetes Complications

Other Information

ATC CodeN/A
Related LinksN/A